The U.S. has ordered another 2.5 million doses of Bavarian Nordic A/S’s Jynneos vaccine that will be available next year as monkeypox continues to spread with more than 1,400 cases reported nationally as of Friday.
The Centers for Disease Control and Prevention expects more infections to be reported in coming days as the government has greatly expanded testing to include several commercial labs, Director Rochelle Walensky said in a press call. The U.S. can now test 70,000 samples a week, up from 6,000, she said.
As cases rise, the demand for vaccines has been much higher than the government’s current supply, frustrating health officials, Walensky said. On Tuesday, a website for vaccine appointments crashed in New York City, where there are 389 cases, due to the number of people trying to secure shots.
